Global Passive Transdermal Drug Delivery Market Insights and Forecast to 2031

Report ID: 1564454 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Passive Transdermal Drug Delivery Product Introduction
    1.2 Market by Type
        1.2.1 Global Passive Transdermal Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Microfluidics
        1.2.3 Smart Pill Technology (SPT)
    1.3 Market by Application
        1.3.1 Global Passive Transdermal Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Passive Transdermal Drug Delivery Sales Estimates and Forecasts 2017-2028
    2.2 Global Passive Transdermal Drug Delivery Revenue Estimates and Forecasts 2017-2028
    2.3 Global Passive Transdermal Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Passive Transdermal Drug Delivery Sales by Region
        2.4.1 Global Passive Transdermal Drug Delivery Sales by Region (2017-2022)
        2.4.2 Global Sales Passive Transdermal Drug Delivery by Region (2023-2028)
    2.5 Global Passive Transdermal Drug Delivery Revenue by Region
        2.5.1 Global Passive Transdermal Drug Delivery Revenue by Region (2017-2022)
        2.5.2 Global Passive Transdermal Drug Delivery Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Passive Transdermal Drug Delivery Sales by Manufacturers
        3.1.1 Global Top Passive Transdermal Drug Delivery Manufacturers by Sales (2017-2022)
        3.1.2 Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Passive Transdermal Drug Delivery in 2021
    3.2 Global Passive Transdermal Drug Delivery Revenue by Manufacturers
        3.2.1 Global Passive Transdermal Drug Delivery Revenue by Manufacturers (2017-2022)
        3.2.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Passive Transdermal Drug Delivery Revenue in 2021
    3.3 Global Passive Transdermal Drug Delivery Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Passive Transdermal Drug Delivery Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Passive Transdermal Drug Delivery Sales by Type
        4.1.1 Global Passive Transdermal Drug Delivery Historical Sales by Type (2017-2022)
        4.1.2 Global Passive Transdermal Drug Delivery Forecasted Sales by Type (2023-2028)
        4.1.3 Global Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2028)
    4.2 Global Passive Transdermal Drug Delivery Revenue by Type
        4.2.1 Global Passive Transdermal Drug Delivery Historical Revenue by Type (2017-2022)
        4.2.2 Global Passive Transdermal Drug Delivery Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2028)
    4.3 Global Passive Transdermal Drug Delivery Price by Type
        4.3.1 Global Passive Transdermal Drug Delivery Price by Type (2017-2022)
        4.3.2 Global Passive Transdermal Drug Delivery Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Passive Transdermal Drug Delivery Sales by Application
        5.1.1 Global Passive Transdermal Drug Delivery Historical Sales by Application (2017-2022)
        5.1.2 Global Passive Transdermal Drug Delivery Forecasted Sales by Application (2023-2028)
        5.1.3 Global Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2028)
    5.2 Global Passive Transdermal Drug Delivery Revenue by Application
        5.2.1 Global Passive Transdermal Drug Delivery Historical Revenue by Application (2017-2022)
        5.2.2 Global Passive Transdermal Drug Delivery Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2017-2028)
    5.3 Global Passive Transdermal Drug Delivery Price by Application
        5.3.1 Global Passive Transdermal Drug Delivery Price by Application (2017-2022)
        5.3.2 Global Passive Transdermal Drug Delivery Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Passive Transdermal Drug Delivery Market Size by Type
        6.1.1 North America Passive Transdermal Drug Delivery Sales by Type (2017-2028)
        6.1.2 North America Passive Transdermal Drug Delivery Revenue by Type (2017-2028)
    6.2 North America Passive Transdermal Drug Delivery Market Size by Application
        6.2.1 North America Passive Transdermal Drug Delivery Sales by Application (2017-2028)
        6.2.2 North America Passive Transdermal Drug Delivery Revenue by Application (2017-2028)
    6.3 North America Passive Transdermal Drug Delivery Market Size by Country
        6.3.1 North America Passive Transdermal Drug Delivery Sales by Country (2017-2028)
        6.3.2 North America Passive Transdermal Drug Delivery Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Passive Transdermal Drug Delivery Market Size by Type
        7.1.1 Europe Passive Transdermal Drug Delivery Sales by Type (2017-2028)
        7.1.2 Europe Passive Transdermal Drug Delivery Revenue by Type (2017-2028)
    7.2 Europe Passive Transdermal Drug Delivery Market Size by Application
        7.2.1 Europe Passive Transdermal Drug Delivery Sales by Application (2017-2028)
        7.2.2 Europe Passive Transdermal Drug Delivery Revenue by Application (2017-2028)
    7.3 Europe Passive Transdermal Drug Delivery Market Size by Country
        7.3.1 Europe Passive Transdermal Drug Delivery Sales by Country (2017-2028)
        7.3.2 Europe Passive Transdermal Drug Delivery Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Passive Transdermal Drug Delivery Market Size by Type
        8.1.1 Asia Pacific Passive Transdermal Drug Delivery Sales by Type (2017-2028)
        8.1.2 Asia Pacific Passive Transdermal Drug Delivery Revenue by Type (2017-2028)
    8.2 Asia Pacific Passive Transdermal Drug Delivery Market Size by Application
        8.2.1 Asia Pacific Passive Transdermal Drug Delivery Sales by Application (2017-2028)
        8.2.2 Asia Pacific Passive Transdermal Drug Delivery Revenue by Application (2017-2028)
    8.3 Asia Pacific Passive Transdermal Drug Delivery Market Size by Region
        8.3.1 Asia Pacific Passive Transdermal Drug Delivery Sales by Region (2017-2028)
        8.3.2 Asia Pacific Passive Transdermal Drug Delivery Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Passive Transdermal Drug Delivery Market Size by Type
        9.1.1 Latin America Passive Transdermal Drug Delivery Sales by Type (2017-2028)
        9.1.2 Latin America Passive Transdermal Drug Delivery Revenue by Type (2017-2028)
    9.2 Latin America Passive Transdermal Drug Delivery Market Size by Application
        9.2.1 Latin America Passive Transdermal Drug Delivery Sales by Application (2017-2028)
        9.2.2 Latin America Passive Transdermal Drug Delivery Revenue by Application (2017-2028)
    9.3 Latin America Passive Transdermal Drug Delivery Market Size by Country
        9.3.1 Latin America Passive Transdermal Drug Delivery Sales by Country (2017-2028)
        9.3.2 Latin America Passive Transdermal Drug Delivery Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Passive Transdermal Drug Delivery Market Size by Type
        10.1.1 Middle East and Africa Passive Transdermal Drug Delivery Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Type (2017-2028)
    10.2 Middle East and Africa Passive Transdermal Drug Delivery Market Size by Application
        10.2.1 Middle East and Africa Passive Transdermal Drug Delivery Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Application (2017-2028)
    10.3 Middle East and Africa Passive Transdermal Drug Delivery Market Size by Country
        10.3.1 Middle East and Africa Passive Transdermal Drug Delivery Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 3M
        11.1.1 3M Corporation Information
        11.1.2 3M Overview
        11.1.3 3M Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 3M Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 3M Recent Developments
    11.2 Actavis, Inc.
        11.2.1 Actavis, Inc. Corporation Information
        11.2.2 Actavis, Inc. Overview
        11.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Actavis, Inc. Recent Developments
    11.3 Bayer AG
        11.3.1 Bayer AG Corporation Information
        11.3.2 Bayer AG Overview
        11.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bayer AG Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bayer AG Recent Developments
    11.4 Boehringer Ingelheim GmbH
        11.4.1 Boehringer Ingelheim GmbH Corporation Information
        11.4.2 Boehringer Ingelheim GmbH Overview
        11.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Boehringer Ingelheim GmbH Recent Developments
    11.5 Corium International, Inc.
        11.5.1 Corium International, Inc. Corporation Information
        11.5.2 Corium International, Inc. Overview
        11.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Corium International, Inc. Recent Developments
    11.6 Echo Therapeutics, Inc.
        11.6.1 Echo Therapeutics, Inc. Corporation Information
        11.6.2 Echo Therapeutics, Inc. Overview
        11.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Echo Therapeutics, Inc. Recent Developments
    11.7 GlaxoSmithKline plc
        11.7.1 GlaxoSmithKline plc Corporation Information
        11.7.2 GlaxoSmithKline plc Overview
        11.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 GlaxoSmithKline plc Recent Developments
    11.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
        11.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
        11.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Overview
        11.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments
    11.9 Mylan N.V.
        11.9.1 Mylan N.V. Corporation Information
        11.9.2 Mylan N.V. Overview
        11.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Mylan N.V. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Mylan N.V. Recent Developments
    11.10 Novartis AG
        11.10.1 Novartis AG Corporation Information
        11.10.2 Novartis AG Overview
        11.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Novartis AG Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Novartis AG Recent Developments
    11.11 Noven Pharmaceuticals, Inc.
        11.11.1 Noven Pharmaceuticals, Inc. Corporation Information
        11.11.2 Noven Pharmaceuticals, Inc. Overview
        11.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Noven Pharmaceuticals, Inc. Recent Developments
    11.12 Transdermal Corp.
        11.12.1 Transdermal Corp. Corporation Information
        11.12.2 Transdermal Corp. Overview
        11.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Transdermal Corp. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Transdermal Corp. Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Passive Transdermal Drug Delivery Industry Chain Analysis
    12.2 Passive Transdermal Drug Delivery Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Passive Transdermal Drug Delivery Production Mode & Process
    12.4 Passive Transdermal Drug Delivery Sales and Marketing
        12.4.1 Passive Transdermal Drug Delivery Sales Channels
        12.4.2 Passive Transdermal Drug Delivery Distributors
    12.5 Passive Transdermal Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Passive Transdermal Drug Delivery Industry Trends
    13.2 Passive Transdermal Drug Delivery Market Drivers
    13.3 Passive Transdermal Drug Delivery Market Challenges
    13.4 Passive Transdermal Drug Delivery Market Restraints
14 Key Findings in The Global Passive Transdermal Drug Delivery Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Passive Transdermal Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Microfluidics
    Table 3. Major Manufacturers of Smart Pill Technology (SPT)
    Table 4. Global Passive Transdermal Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Passive Transdermal Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Passive Transdermal Drug Delivery Sales by Region (2017-2022) & (K Units)
    Table 7. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2017-2022)
    Table 8. Global Passive Transdermal Drug Delivery Sales by Region (2023-2028) & (K Units)
    Table 9. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2023-2028)
    Table 10. Global Passive Transdermal Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2017-2022)
    Table 12. Global Passive Transdermal Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2023-2028)
    Table 14. Global Passive Transdermal Drug Delivery Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Passive Transdermal Drug Delivery Sales Share by Manufacturers (2017-2022)
    Table 16. Global Passive Transdermal Drug Delivery Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers (2017-2022)
    Table 18. Passive Transdermal Drug Delivery Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Passive Transdermal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Passive Transdermal Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Passive Transdermal Drug Delivery as of 2021)
    Table 21. Passive Transdermal Drug Delivery Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Passive Transdermal Drug Delivery Product Offered
    Table 23. Date of Manufacturers Enter into Passive Transdermal Drug Delivery Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 26. Global Passive Transdermal Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 27. Global Passive Transdermal Drug Delivery Sales Share by Type (2017-2022)
    Table 28. Global Passive Transdermal Drug Delivery Sales Share by Type (2023-2028)
    Table 29. Global Passive Transdermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Passive Transdermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Passive Transdermal Drug Delivery Revenue Share by Type (2017-2022)
    Table 32. Global Passive Transdermal Drug Delivery Revenue Share by Type (2023-2028)
    Table 33. Passive Transdermal Drug Delivery Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Passive Transdermal Drug Delivery Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 36. Global Passive Transdermal Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 37. Global Passive Transdermal Drug Delivery Sales Share by Application (2017-2022)
    Table 38. Global Passive Transdermal Drug Delivery Sales Share by Application (2023-2028)
    Table 39. Global Passive Transdermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Passive Transdermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Passive Transdermal Drug Delivery Revenue Share by Application (2017-2022)
    Table 42. Global Passive Transdermal Drug Delivery Revenue Share by Application (2023-2028)
    Table 43. Passive Transdermal Drug Delivery Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Passive Transdermal Drug Delivery Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 46. North America Passive Transdermal Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 47. North America Passive Transdermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Passive Transdermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 50. North America Passive Transdermal Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 51. North America Passive Transdermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Passive Transdermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 54. North America Passive Transdermal Drug Delivery Sales by Country (2023-2028) & (K Units)
    Table 55. North America Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Passive Transdermal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Passive Transdermal Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Passive Transdermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Passive Transdermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Passive Transdermal Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Passive Transdermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Passive Transdermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Passive Transdermal Drug Delivery Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Passive Transdermal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Passive Transdermal Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Passive Transdermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Passive Transdermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Passive Transdermal Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Passive Transdermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Passive Transdermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Passive Transdermal Drug Delivery Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Passive Transdermal Drug Delivery Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Passive Transdermal Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Passive Transdermal Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Passive Transdermal Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Passive Transdermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Passive Transdermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Passive Transdermal Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Passive Transdermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Passive Transdermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Passive Transdermal Drug Delivery Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Passive Transdermal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Passive Transdermal Drug Delivery Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Passive Transdermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Passive Transdermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Passive Transdermal Drug Delivery Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Passive Transdermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Passive Transdermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Passive Transdermal Drug Delivery Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
    Table 105. 3M Corporation Information
    Table 106. 3M Description and Major Businesses
    Table 107. 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. 3M Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. 3M Recent Developments
    Table 110. Actavis, Inc. Corporation Information
    Table 111. Actavis, Inc. Description and Major Businesses
    Table 112. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Actavis, Inc. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Actavis, Inc. Recent Developments
    Table 115. Bayer AG Corporation Information
    Table 116. Bayer AG Description and Major Businesses
    Table 117. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Bayer AG Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Bayer AG Recent Developments
    Table 120. Boehringer Ingelheim GmbH Corporation Information
    Table 121. Boehringer Ingelheim GmbH Description and Major Businesses
    Table 122. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Boehringer Ingelheim GmbH Recent Developments
    Table 125. Corium International, Inc. Corporation Information
    Table 126. Corium International, Inc. Description and Major Businesses
    Table 127. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Corium International, Inc. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Corium International, Inc. Recent Developments
    Table 130. Echo Therapeutics, Inc. Corporation Information
    Table 131. Echo Therapeutics, Inc. Description and Major Businesses
    Table 132. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Echo Therapeutics, Inc. Recent Developments
    Table 135. GlaxoSmithKline plc Corporation Information
    Table 136. GlaxoSmithKline plc Description and Major Businesses
    Table 137. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. GlaxoSmithKline plc Recent Developments
    Table 140. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
    Table 141. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Major Businesses
    Table 142. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments
    Table 145. Mylan N.V. Corporation Information
    Table 146. Mylan N.V. Description and Major Businesses
    Table 147. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Mylan N.V. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Mylan N.V. Recent Developments
    Table 150. Novartis AG Corporation Information
    Table 151. Novartis AG Description and Major Businesses
    Table 152. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Novartis AG Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Novartis AG Recent Developments
    Table 155. Noven Pharmaceuticals, Inc. Corporation Information
    Table 156. Noven Pharmaceuticals, Inc. Description and Major Businesses
    Table 157. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 158. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Noven Pharmaceuticals, Inc. Recent Developments
    Table 160. Transdermal Corp. Corporation Information
    Table 161. Transdermal Corp. Description and Major Businesses
    Table 162. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 163. Transdermal Corp. Passive Transdermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Transdermal Corp. Recent Developments
    Table 165. Key Raw Materials Lists
    Table 166. Raw Materials Key Suppliers Lists
    Table 167. Passive Transdermal Drug Delivery Distributors List
    Table 168. Passive Transdermal Drug Delivery Customers List
    Table 169. Passive Transdermal Drug Delivery Market Trends
    Table 170. Passive Transdermal Drug Delivery Market Drivers
    Table 171. Passive Transdermal Drug Delivery Market Challenges
    Table 172. Passive Transdermal Drug Delivery Market Restraints
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Passive Transdermal Drug Delivery Product Picture
    Figure 3. Global Passive Transdermal Drug Delivery Market Share by Type in 2021 & 2028
    Figure 3. Microfluidics Product Picture
    Figure 4. Smart Pill Technology (SPT) Product Picture
    Figure 5. Global Passive Transdermal Drug Delivery Market Share by Application in 2021 & 2028
    Figure 6. Clinic
    Figure 7. Hospital
    Figure 8. Others
    Figure 9. Passive Transdermal Drug Delivery Report Years Considered
    Figure 10. Global Passive Transdermal Drug Delivery Sales 2017-2028 (K Units)
    Figure 11. Global Passive Transdermal Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Passive Transdermal Drug Delivery Revenue 2017-2028 (US$ Million)
    Figure 13. Global Passive Transdermal Drug Delivery Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2017-2022)
    Figure 15. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2023-2028)
    Figure 16. North America Passive Transdermal Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Passive Transdermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Passive Transdermal Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Passive Transdermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Passive Transdermal Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Passive Transdermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Passive Transdermal Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Passive Transdermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Passive Transdermal Drug Delivery Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Passive Transdermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Passive Transdermal Drug Delivery Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Passive Transdermal Drug Delivery in the World: Market Share by Passive Transdermal Drug Delivery Revenue in 2021
    Figure 28. Global Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 30. Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 31. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 32. Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 33. North America Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 34. North America Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 35. North America Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 36. North America Passive Transdermal Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 37. North America Passive Transdermal Drug Delivery Sales Share by Country (2017-2028)
    Figure 38. North America Passive Transdermal Drug Delivery Revenue Share by Country (2017-2028)
    Figure 39. U.S. Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 42. Europe Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 44. Europe Passive Transdermal Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Passive Transdermal Drug Delivery Sales Share by Country (2017-2028)
    Figure 46. Europe Passive Transdermal Drug Delivery Revenue Share by Country (2017-2028)
    Figure 47. Germany Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 48. France Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Passive Transdermal Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Passive Transdermal Drug Delivery Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Passive Transdermal Drug Delivery Revenue Share by Region (2017-2028)
    Figure 58. China Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 61. India Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Passive Transdermal Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Passive Transdermal Drug Delivery Sales Share by Country (2017-2028)
    Figure 73. Latin America Passive Transdermal Drug Delivery Revenue Share by Country (2017-2028)
    Figure 74. Mexico Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Passive Transdermal Drug Delivery Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Passive Transdermal Drug Delivery Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Passive Transdermal Drug Delivery Revenue Share by Country (2017-2028)
    Figure 83. Turkey Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Passive Transdermal Drug Delivery Revenue (2017-2028) & (US$ Million)
    Figure 86. Passive Transdermal Drug Delivery Value Chain
    Figure 87. Passive Transdermal Drug Delivery Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Frequently Asked Questions
Passive Transdermal Drug Delivery report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Passive Transdermal Drug Delivery report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Passive Transdermal Drug Delivery report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Biometrics Banking

Biometrics Banking market is segmented by players, region (country), by Type and by Application.  ... Read More

Blemish Balm Product

Blemish Balm Product market is segmented by Type and by Application. Players, stakeholders, and o ... Read More